Literature DB >> 730349

Effect of immunization on susceptibility to experimental Streptococcus mutans and Streptococcus sanguis endocarditis.

D T Durack, B C Gilliland, R G Petersdorf.   

Abstract

It has been asserted that humoral immunity is an important potentiating factor in pathogenesis of infective endocarditis, in that prior immunization to certain bacteria may predispose the host to endocarditis caused by those organisms. If so, possible future vaccination of humans with streptococcal antigens for the prevention of dental caries might increase the susceptibility of the population to streptococcal endocarditis. To examine this hypothesis further, we immunized rabbits with killed Streptococcus sanguis or Streptococcus mutans. After complement-fixing antibody had developed, the rabbits were tested for susceptibility to experimental infective endocarditis. Rabbits with high titers of complement-fixing antibody to the infecting organism developed streptococcal endocarditis less often (13%) than animals with lower titers (69%; P less than 0.0002). These findings do not support the hypothesis that pre-immunization predisposes to infective endocarditis and lend no credence to the concept that vaccination of human subjects against dental caries might increase their susceptibility to streptococcal endocarditis. On the contrary, the results of these experiments indicate that specific antibody can confer relative immunity to infective endocarditis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 730349      PMCID: PMC422114          DOI: 10.1128/iai.22.1.52-56.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Prevention of Streptococcus mutans infection of tooth surfaces by salivary antibody in Irus monkeys (Macaca fascicularis).

Authors:  R T Evans; F G Emmings; R J Genco
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

2.  Meningococcal Endocarditis in Immunized Horses.

Authors:  J K Miller
Journal:  Am J Pathol       Date:  1944-03       Impact factor: 4.307

Review 3.  Pathoanatomic, pathophysiologic and clinical correlations in endocarditis (first of two parts).

Authors:  L Weinstein; J J Schlesinger
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

Review 4.  Infective endocarditis--1973.

Authors:  L Weinstein; R H Rubin
Journal:  Prog Cardiovasc Dis       Date:  1973 Nov-Dec       Impact factor: 8.194

5.  Rheumatoid factors in subacute bacterial endocarditis--bacterium, duration of disease or genetic predisposition?

Authors:  R P Messner; T Laxdal; P G Quie; R C Williams
Journal:  Ann Intern Med       Date:  1968-04       Impact factor: 25.391

6.  An immunological investigation into the prevention of caries in deciduous teeth of rhesus monkeys.

Authors:  T Lehner; S J Challacombe; J Caldwell
Journal:  Arch Oral Biol       Date:  1975 May-Jun       Impact factor: 2.633

7.  Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.

Authors:  L L Pelletier; D T Durack; R G Petersdorf
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

8.  Circulating immune complexes in infective endocarditis.

Authors:  A S Bayer; A N Theofilopoulos; R Eisenberg; F J Dixon; L B Guze
Journal:  N Engl J Med       Date:  1976-12-30       Impact factor: 91.245

9.  Stress concentrations at the apex of pinned, implanted teeth.

Authors:  S C Gambrell; J M Allen
Journal:  J Dent Res       Date:  1976 Jan-Feb       Impact factor: 6.116

10.  Effects of local immunization with Streptococcus mutans on induction of salivary immunoglobulin A antibody and experimental dental caries in rats.

Authors:  M A Talbman; D J Smith
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

View more
  19 in total

1.  Role of adherence in infective endocarditis.

Authors:  M A Kielhofner; R J Hamill
Journal:  Tex Heart Inst J       Date:  1989

2.  Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats.

Authors:  H B Viscount; C L Munro; D Burnette-Curley; D L Peterson; F L Macrina
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Antibodies Targeting Hsa and PadA Prevent Platelet Aggregation and Protect Rats against Experimental Endocarditis Induced by Streptococcus gordonii.

Authors:  Stefano Mancini; Carmen Menzi; Frank Oechslin; Philippe Moreillon; José Manuel Entenza
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

4.  Analysis of cross-protection between serotypes and passively transferred immune globulin in experimental nutritionally variant streptococcal endocarditis.

Authors:  I van de Rijn
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

5.  Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis.

Authors:  W M Scheld; R A Calderone; J P Brodeur; M A Sande
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Glucosyltransferase mediates adhesion of Streptococcus gordonii to human endothelial cells in vitro.

Authors:  A M Vacca-Smith; C A Jones; M J Levine; M W Stinson
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Role of culture conditions and immunization in experimental nutritionally variant streptococcal endocarditis.

Authors:  I van de Rijn
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Role of granulocytes in experimental Streptococcus sanguis endocarditis.

Authors:  M J Meddens; J Thompson; F Eulderink; W C Bauer; H Mattie; R van Furth
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

9.  Adherence of Staphylococcus epidermidis to fibrin-platelet clots in vitro mediated by lipoteichoic acid.

Authors:  T D Chugh; G J Burns; H J Shuhaiber; G M Bahr
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

10.  Influence of Staphylococcus aureus antibody on experimental endocarditis in rabbits.

Authors:  D P Greenberg; J I Ward; A S Bayer
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.